NUWE Nuwellis
- 1.2100
- -0.0300-2.42%
- 1.2002
- -0.0098-0.81%
Nuwellis News
Nuwellis Files for Secondary Stock Offering
Maxim Group Maintains Nuwellis(NUWE.US) With Hold Rating
10-Q: Q3 2024 Earnings Report
8-K: Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
12 Health Care Stocks Moving In Monday's Pre-Market Session
Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript Summary
Nuwellis Shares Are Trading Higher After the Company Reported Better-than-expected Q3 Revenue Results.
RAPT Therapeutics RAPT Program Terminated; Nuwellis NUWE Earnings
Nuwellis GAAP EPS of $1.74 Beats by $3.02, Revenue of $2.34M Misses by $0.06M
Express News | Nuwellis Inc: Got Notice of 297% Rise to $1,639 per Day in Reimbursement From CMS
Nuwellis 3Q EPS $1.74 >NUWE
Earnings Flash (NUWE) NUWELLIS Reports Q3 Revenue $2.4M
Express News | Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
Press Release: Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights
Earnings Scheduled For November 11, 2024
Examining the Future: Nuwellis's Earnings Outlook
Nuwellis Q3 Earnings Preview
Earnings Preview: Nuwellis to Report Financial Results Pre-market on November 11
$Nuwellis(NUWE.US)$ is scheduled to release its financial results pre-market on November 11 ET. Earnings PreviewAnalysts estimate $Nuwellis(NUWE.US)$ to post revenue of USD2.40M for 2024Q3, down 0.5%
Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds
Nuwellis NUWE CMS Reimbursement; Singular Genomics OMIC Acquisition Offer
Analysis
Price Target
No Data
No Data